Conatumumab Antibody
Conatumumab (AMG 655) is an agonistic monoclonal antibody targeting Death Receptor 5 (DR5/TRAIL-R2) with high affinity, inducing caspase-mediated apoptosis in tumor cells. It has been investigated in preclinical in vitro and in vivo studies for advanced solid tumors, including colorectal and pancreatic cancers.
Product Specifications
Product Name Alternative
AMG 655, AMG655, AMG-655, Conatumumab, DR5, TRAIL-R2 mAb
Target
TNF
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology
Concentration
3.43 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
145.44 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog